Super-Sized flu shot shows promise for seniors
NCT ID NCT04537234
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tested a high-dose flu vaccine in 165 adults aged 65 and older in Taiwan. The goal was to see if it produced a stronger immune response and was safe compared to a standard flu shot. Participants received either the high-dose or standard vaccine, and researchers measured antibody levels and side effects over 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA (HEALTHY VOLUNTEERS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number 1580001
Taipei, 100, Taiwan
-
Investigational Site Number 1580002
Taipei, 112, Taiwan
-
Investigational Site Number 1580003
Taoyuan, 333, Taiwan
-
Investigational Site Number 1580004
Taichung, 40447, Taiwan
Conditions
Explore the condition pages connected to this study.